Clinical Trials, Pharmaceutical, Biotechnology, Clinical Research.
model at risk, according to Kent Thoelke, executive vice president of scientific, medical affairs and safety, commercialization services, at PRA Health Sciences. Thoelke, who spoke at the first Bridging Clinical Research & Clinical Health Care Collaborative April 4 to 5, in ​National Harbor,